The erectile dysfunction devices market size has grown rapidly in recent years. It will grow from $2.09 billion in 2025 to $2.35 billion in 2026 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to rising prevalence of diabetes, increasing incidence of cardiovascular diseases, growing aging male population, increased awareness of erectile dysfunction treatments, expanding availability of urology care services.
The erectile dysfunction devices market size is expected to see rapid growth in the next few years. It will grow to $3.73 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related disorders, growing male health awareness, increasing acceptance of medical devices for sexual health, expanding access to minimally invasive treatments, improving healthcare infrastructure in emerging markets. Major trends in the forecast period include rising adoption of non-invasive erectile dysfunction devices, growing preference for at-home erectile dysfunction management, increasing demand for vacuum erection and penile pump devices, rising acceptance of surgical penile implants in severe ed cases, growing focus on personalized erectile dysfunction treatment.
The rising prevalence of prostate cancer is expected to drive the growth of the erectile dysfunction devices market. Prostate cancer, originating in the prostate gland - a small organ below the bladder responsible for producing part of semen - affects a significant number of men. The increase in prostate cancer cases is linked to aging populations, better detection methods, and lifestyle factors that may influence the disease's prevalence. Erectile dysfunction devices are crucial for prostate cancer patients, as they help restore sexual function and enhance quality of life after treatment, which can often affect erectile capabilities. For instance, in September 2025, according to the American Cancer Society, a US-based professional organization, approximately 313,780 new cases of prostate cancer are expected in the United States in 2025. The risk of developing prostate cancer increases significantly with age, rising from 0.2% in men under 50 to 6.5% in those aged 70-79. Hence, the increasing prevalence of prostate cancer is fueling the growth of the erectile dysfunction devices market.
Leading companies in the erectile dysfunction devices market are focusing on developing advanced, non-invasive products to gain a competitive edge. Non-invasive erectile dysfunction devices are medical tools designed to improve or restore erectile function without surgical intervention, often using methods such as vacuum therapy, electrical stimulation, or non-penetrative penile implants. For example, in June 2024, Ohh Med Medical, an Israel-based medical equipment manufacturer, introduced the VerticaPlus device for erectile dysfunction. This innovative device includes a cloud-based mobile app that enhances the therapy experience with real-time feedback and quality tracking. The upgraded version features the app as a personal coach, offering ongoing feedback, step-by-step tutorials, and customized settings for more effective therapy.
In May 2025, Shanghai Taiyuan Life Science, a China-based biotechnology company, partnered with Initia Ltd. to advance next-generation biologic solutions in life sciences. The collaboration aims to expand access to, and distribution of, high-quality biologic products, improving patient outcomes while driving innovation and growth in the biologics market. Initia Ltd. is a UK-based biotechnology company specializing in the commercialization of advanced biologics for therapeutic applications.
Major companies operating in the erectile dysfunction devices market are Boston Scientific Corporation, Coloplast Corporation, MTS Medical AG, Alma Lasers Ltd., Shenzhen Huikang Medical Apparatus Co Ltd, Storz Medical AG, UroMatrix Medical Systems, Medispec Ltd., Zephyr Surgical Implants, Timm Medical Technologies Inc., Promedon GmbH, Zimmer MedizinSysteme GmbH, Rigicon Inc., NOVAmedtek, Vacurect, The Elator, Silimed Indústria de Implantes, Restore Medical Inc, Medtronic plc, Titan Medical Inc, Encore Medical Ltd.
North America was the largest region in the erectile dysfunction devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the erectile dysfunction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the erectile dysfunction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the erectile dysfunction devices market by increasing costs for imported medical-grade materials, mechanical components, and precision-manufactured implant parts. These impacts are most pronounced across surgical devices and advanced non-surgical systems, particularly in regions dependent on international manufacturing such as asia-pacific and europe. Higher device costs have influenced pricing and reimbursement dynamics in hospitals and specialty clinics. At the same time, tariffs are encouraging local manufacturing, supplier diversification, and cost-efficient device design, creating long-term opportunities for regional players.
The erectile dysfunction devices market research report is one of a series of new reports that provides erectile dysfunction devices market statistics, including erectile dysfunction devices industry global market size, regional shares, competitors with a erectile dysfunction devices market share, detailed erectile dysfunction devices market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction devices industry. This erectile dysfunction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Erectile dysfunction devices are medical instruments intended to assist individuals with erectile dysfunction (ED) in achieving and sustaining an erection adequate for sexual activity. These devices utilize various methods, including suction, constriction, or medication delivery, to enhance blood flow to the penis or support its firmness.
There are two primary types of erectile dysfunction devices non-surgical and surgical. Non-surgical devices are designed to help men achieve and maintain an erection without the need for surgery. They are used to address conditions such as diabetes, neurological disorders, and hypertension, and can be either invasive or non-invasive. These devices cater to different age groups - under 40 years, 40-60 years, and over 60 years - and are utilized by various end-users including hospitals, clinics, ambulatory surgical centers, and others.
The erectile dysfunction devices market consists of sales of penile prostheses, injection therapy devices, urethral suppositories, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The erectile dysfunction devices market size is expected to see rapid growth in the next few years. It will grow to $3.73 billion in 2030 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be attributed to rising prevalence of lifestyle-related disorders, growing male health awareness, increasing acceptance of medical devices for sexual health, expanding access to minimally invasive treatments, improving healthcare infrastructure in emerging markets. Major trends in the forecast period include rising adoption of non-invasive erectile dysfunction devices, growing preference for at-home erectile dysfunction management, increasing demand for vacuum erection and penile pump devices, rising acceptance of surgical penile implants in severe ed cases, growing focus on personalized erectile dysfunction treatment.
The rising prevalence of prostate cancer is expected to drive the growth of the erectile dysfunction devices market. Prostate cancer, originating in the prostate gland - a small organ below the bladder responsible for producing part of semen - affects a significant number of men. The increase in prostate cancer cases is linked to aging populations, better detection methods, and lifestyle factors that may influence the disease's prevalence. Erectile dysfunction devices are crucial for prostate cancer patients, as they help restore sexual function and enhance quality of life after treatment, which can often affect erectile capabilities. For instance, in September 2025, according to the American Cancer Society, a US-based professional organization, approximately 313,780 new cases of prostate cancer are expected in the United States in 2025. The risk of developing prostate cancer increases significantly with age, rising from 0.2% in men under 50 to 6.5% in those aged 70-79. Hence, the increasing prevalence of prostate cancer is fueling the growth of the erectile dysfunction devices market.
Leading companies in the erectile dysfunction devices market are focusing on developing advanced, non-invasive products to gain a competitive edge. Non-invasive erectile dysfunction devices are medical tools designed to improve or restore erectile function without surgical intervention, often using methods such as vacuum therapy, electrical stimulation, or non-penetrative penile implants. For example, in June 2024, Ohh Med Medical, an Israel-based medical equipment manufacturer, introduced the VerticaPlus device for erectile dysfunction. This innovative device includes a cloud-based mobile app that enhances the therapy experience with real-time feedback and quality tracking. The upgraded version features the app as a personal coach, offering ongoing feedback, step-by-step tutorials, and customized settings for more effective therapy.
In May 2025, Shanghai Taiyuan Life Science, a China-based biotechnology company, partnered with Initia Ltd. to advance next-generation biologic solutions in life sciences. The collaboration aims to expand access to, and distribution of, high-quality biologic products, improving patient outcomes while driving innovation and growth in the biologics market. Initia Ltd. is a UK-based biotechnology company specializing in the commercialization of advanced biologics for therapeutic applications.
Major companies operating in the erectile dysfunction devices market are Boston Scientific Corporation, Coloplast Corporation, MTS Medical AG, Alma Lasers Ltd., Shenzhen Huikang Medical Apparatus Co Ltd, Storz Medical AG, UroMatrix Medical Systems, Medispec Ltd., Zephyr Surgical Implants, Timm Medical Technologies Inc., Promedon GmbH, Zimmer MedizinSysteme GmbH, Rigicon Inc., NOVAmedtek, Vacurect, The Elator, Silimed Indústria de Implantes, Restore Medical Inc, Medtronic plc, Titan Medical Inc, Encore Medical Ltd.
North America was the largest region in the erectile dysfunction devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the erectile dysfunction devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the erectile dysfunction devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the erectile dysfunction devices market by increasing costs for imported medical-grade materials, mechanical components, and precision-manufactured implant parts. These impacts are most pronounced across surgical devices and advanced non-surgical systems, particularly in regions dependent on international manufacturing such as asia-pacific and europe. Higher device costs have influenced pricing and reimbursement dynamics in hospitals and specialty clinics. At the same time, tariffs are encouraging local manufacturing, supplier diversification, and cost-efficient device design, creating long-term opportunities for regional players.
The erectile dysfunction devices market research report is one of a series of new reports that provides erectile dysfunction devices market statistics, including erectile dysfunction devices industry global market size, regional shares, competitors with a erectile dysfunction devices market share, detailed erectile dysfunction devices market segments, market trends and opportunities, and any further data you may need to thrive in the erectile dysfunction devices industry. This erectile dysfunction devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Erectile dysfunction devices are medical instruments intended to assist individuals with erectile dysfunction (ED) in achieving and sustaining an erection adequate for sexual activity. These devices utilize various methods, including suction, constriction, or medication delivery, to enhance blood flow to the penis or support its firmness.
There are two primary types of erectile dysfunction devices non-surgical and surgical. Non-surgical devices are designed to help men achieve and maintain an erection without the need for surgery. They are used to address conditions such as diabetes, neurological disorders, and hypertension, and can be either invasive or non-invasive. These devices cater to different age groups - under 40 years, 40-60 years, and over 60 years - and are utilized by various end-users including hospitals, clinics, ambulatory surgical centers, and others.
The erectile dysfunction devices market consists of sales of penile prostheses, injection therapy devices, urethral suppositories, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Erectile Dysfunction Devices Market Characteristics
3. Erectile Dysfunction Devices Market Supply Chain Analysis
4. Global Erectile Dysfunction Devices Market Trends and Strategies
5. Erectile Dysfunction Devices Market Analysis of End Use Industries
7. Global Erectile Dysfunction Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Erectile Dysfunction Devices Total Addressable Market (TAM) Analysis for the Market
9. Erectile Dysfunction Devices Market Segmentation
10. Erectile Dysfunction Devices Market Regional and Country Analysis
11. Asia-Pacific Erectile Dysfunction Devices Market
12. China Erectile Dysfunction Devices Market
13. India Erectile Dysfunction Devices Market
14. Japan Erectile Dysfunction Devices Market
15. Australia Erectile Dysfunction Devices Market
16. Indonesia Erectile Dysfunction Devices Market
17. South Korea Erectile Dysfunction Devices Market
18. Taiwan Erectile Dysfunction Devices Market
19. South East Asia Erectile Dysfunction Devices Market
20. Western Europe Erectile Dysfunction Devices Market
21. UK Erectile Dysfunction Devices Market
22. Germany Erectile Dysfunction Devices Market
23. France Erectile Dysfunction Devices Market
24. Italy Erectile Dysfunction Devices Market
25. Spain Erectile Dysfunction Devices Market
26. Eastern Europe Erectile Dysfunction Devices Market
27. Russia Erectile Dysfunction Devices Market
28. North America Erectile Dysfunction Devices Market
29. USA Erectile Dysfunction Devices Market
30. Canada Erectile Dysfunction Devices Market
31. South America Erectile Dysfunction Devices Market
32. Brazil Erectile Dysfunction Devices Market
33. Middle East Erectile Dysfunction Devices Market
34. Africa Erectile Dysfunction Devices Market
36. Erectile Dysfunction Devices Market Competitive Landscape and Company Profiles
37. Erectile Dysfunction Devices Market Other Major and Innovative Companies
40. Erectile Dysfunction Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Erectile Dysfunction Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses erectile dysfunction devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for erectile dysfunction devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The erectile dysfunction devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Non-Surgical Devices; Surgical Devices2) By Cause: Diabetes; Neurological Disorders; Hypertension; Other Causes
3) By Approach: Invasive; Non-Invasive
4) By Age Group: Less Than 40 Years; 40-60 Years; More Than 60 Years
5) By End-User: Hospitals; Clinics; Ambulatory Surgical Centers; Other End-Users
Subsegments:
1) By Non-Surgical Devices: Penile Pumps (Vacuum Erection Devices); External Penile Prostheses; Erectile Dysfunction Medications (Oral, Topical); Penile Traction Devices; Intraurethral Suppositories2) By Surgical Devices: Penile Implants (Inflatable, Semi-Rigid); Penile Prostheses (Inflatable, Non-Inflatable); Vascular Surgery Devices (Penile Artery Surgery)
Companies Mentioned: Boston Scientific Corporation; Coloplast Corporation; MTS Medical AG; Alma Lasers Ltd.; Shenzhen Huikang Medical Apparatus Co Ltd; Storz Medical AG; UroMatrix Medical Systems; Medispec Ltd.; Zephyr Surgical Implants; Timm Medical Technologies Inc.; Promedon GmbH; Zimmer MedizinSysteme GmbH; Rigicon Inc.; NOVAmedtek; Vacurect; The Elator; Silimed Indústria de Implantes; Restore Medical Inc; Medtronic plc; Titan Medical Inc; Encore Medical Ltd
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Erectile Dysfunction Devices market report include:- Boston Scientific Corporation
- Coloplast Corporation
- MTS Medical AG
- Alma Lasers Ltd.
- Shenzhen Huikang Medical Apparatus Co Ltd
- Storz Medical AG
- UroMatrix Medical Systems
- Medispec Ltd.
- Zephyr Surgical Implants
- Timm Medical Technologies Inc.
- Promedon GmbH
- Zimmer MedizinSysteme GmbH
- Rigicon Inc.
- NOVAmedtek
- Vacurect
- The Elator
- Silimed Indústria de Implantes
- Restore Medical Inc
- Medtronic plc
- Titan Medical Inc
- Encore Medical Ltd
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.35 Billion |
| Forecasted Market Value ( USD | $ 3.73 Billion |
| Compound Annual Growth Rate | 12.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
